Literature DB >> 10150867

Nutritional supplement use and age-related macular degeneration.

E Y Chew1.   

Abstract

Age-related macular degeneration is one of the leading causes of visual loss among people aged 65 years or older. The causes and factors associated with the progression of age-related macular degeneration are unknown presently. Basic research and epidemiologic data support the hypotheses that higher levels of antioxidant vitamins and minerals may protect the eye from the development of age-related macular degeneration. For this reason and also because of the lack of effective treatment for most cases of age-related macular degeneration, nutritional supplements with antioxidants have emerged as possible therapy for age-related macular degeneration. Nutritional supplements are not proven therapy for age-related macular degeneration. The potential beneficial effects and adverse side effects of the nutritional supplements have not yet been fully evaluated in carefully conducted clinical trials. Several randomized placebo-controlled clinical trials are presently underway. Results of these studies will provide important data to clarify the potential beneficial and adverse effects of such treatment. Until these results are available, it would be premature to make recommendations in favor of vitamin or mineral supplements.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 10150867     DOI: 10.1097/00055735-199506000-00004

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  2 in total

Review 1.  The genetics of complex ophthalmic disorders.

Authors:  K Evans; A C Bird
Journal:  Br J Ophthalmol       Date:  1996-08       Impact factor: 4.638

2.  Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchanger.

Authors:  Jaya P Gnana-Prakasam; Muthusamy Thangaraju; Kebin Liu; Yonju Ha; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2009-11-11       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.